Latest Neurizon Therapeutics News & Updates

See the latest news and media coverage for Neurizon. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Neurizon Therapeutics (Neurizon)

Biotechnology company developing neurodegenerative disease treatments

neurizon.com
Headquarters
Melbourne, Australia
Company type
Public company
Number of employees
2–15
Industry
Pharmaceuticals

Last updated

Latest news about Neurizon Therapeutics (Neurizon)

In short: Neurizon Therapeutics accelerated its NUZ-001 ALS trial timeline after completing enrollment early and securing over $44 million in funding.

Company announcements

Neurizon

Neurizon announces change of director's interest

The document outlines the change in holdings of a director as required by ASX listing rules.

Unlock all announcements with a

Media coverage

Yahoo Finance

Neurizon Therapeutics Limited (NUZ.AX)

Get the latest Neurizon Therapeutics Limited (NUZ.AX) stock news and headlines to help you in your trading and investing decisions.

The Australian

Neurizon ALS platform trial passes 50pc dosing milestone ahead of schedule

Neurizon Therapeutics has announced more than half of the planned 240 participants in Regimen I of its ALS platform trial ...

Unlock all articles with a

Never miss news about Neurizon

Track Neurizon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Neurizon competitors & trending companies

Browse news for competitors to Neurizon and other trending companies.